Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17046101 | 0.78 | ALDH1A1 (0.47) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL17041908 | 0.78 | ALDH1A1 (0.47) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL13166302 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL3035987 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL13166304 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL13166298 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL1485899 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL3036481 | 0.78 | ALDH1A1 (0.53) | ALDH1A1HSD17B10EPHX2KDM4ESIGMAR1 | |
| SCHEMBL8918 | 0.78 | — | — | |
| SCHEMBL1148684 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2189485-B1 | Polyurethane composition comprising alpha-silane having anisostropic material properties | SIKA TECHNOLOGY AG (CH) | 2011-02-16 | — | — | EP | claimed |
| US-20260125587-A1 | PROCESS FOR PRODUCING A STORAGE-STABLE ACTIVATOR FOR GLASS AND CERAMIC SUBSTRATES | SIKA TECHNOLOGY AG (CH) | 2026-05-07 | — | — | US | disclosed |
| EP-3585851-B1 | AIR AND WATER BARRIER ARTICLE INCLUDING INELASTIC POROUS LAYER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-01 | — | — | EP | disclosed |
| US-20260062596-A1 | SILANE-TERMINATED POLYMERS | MERZ + BENTELI AG (CH) | 2026-03-05 | — | — | US | disclosed |
| EP-4703405-A1 | CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4692259-A1 | PRIMER COMPOSITION AND LAMINATE | Kaneka Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260028450-A1 | SILANE-TERMINATED POLYMERS | MERZ + BENTELI AG (CH) | 2026-01-29 | — | — | US | disclosed |
| EP-3929260-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4484500-B1 | CURABLE COMPOSITION, CURED PRODUCT THEREOF, ADHESIVE AGENT COMPRISING THE COMPOSITION AND LAMINATED BODY | KANEKA CORP (JP) | 2025-11-26 | — | — | EP | disclosed |
| EP-4011978-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2025-11-19 | — | — | EP | disclosed |
| US-20100043945-A1 | LOW-TEMPERATURE ADHESIVE UNDERCOAT COMPOSITION | SIKA TECHNOLOGY AG (CH) | 2010-02-25 | — | — | US | disclosed |
| US-20090297856-A1 | Adhesion promoter composition comprising epoxy resin | SIKA TECHNOLOGY AG (CH) | 2009-12-03 | — | — | US | disclosed |
| US-20090264612-A1 | ALKOXYSILANE-TERMINATED PREPOLYMERS | WACKER CHEMIE AG (DE) | 2009-10-22 | — | — | US | disclosed |
| US-20090240072-A1 | Mixing Device for Liquids | SIKA TECHNOLOGY AG (CH) | 2009-09-24 | — | — | US | disclosed |
| US-20090226738-A1 | AQUEOUS ADHESION PROMOTER COMPOSITION COMPRISING AN AMINOSILANE AND A MERCAPTOSILANE | SIKA TECHNOLOGY AG (CH) | 2009-09-10 | — | — | US | disclosed |
| US-20090053411-A1 | Surfactant-stabilized organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2009-02-26 | — | — | US | disclosed |
| US-20080314518-A1 | Aqueous two-component organoalkoxysilane composition | SUTTER JOLANDA | 2008-12-25 | — | — | US | disclosed |
| US-20070190345-A1 | Aqueous two-component organoalkoxysilane composition | SIKA TECHNOLOGY AG (CH) | 2007-08-16 | — | — | US | disclosed |
| US-20070167598-A1 | Prepolymers with alkoxysilane end groups | CONSORTIUM FUER ELEKTROCHEMISCHE GMBH (DE) | 2007-07-19 | — | — | US | disclosed |
| US-20070100111-A1 | Alkoxysilane terminated prepolymers | CONSORTIUM FUER ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125587-A1 | PROCESS FOR PRODUCING A STORAGE-STABLE ACTIVATOR FOR GLASS AND CERAMIC SUBSTRATES | CD40LG, CDH1, VCAM1 | ALDH1A1 435/4885HSD17B10 3945/4885NPSR1 2231/4885 |
| US-20090053411-A1 | Surfactant-stabilized organoalkoxysilane composition | TST, STS, SMURF1 | ALDH1A1 4417/4885HSD17B10 3223/4885NPSR1 465/4885 |
| US-20260062596-A1 | SILANE-TERMINATED POLYMERS | SMC4, PCNA, AKT1 | ALDH1A1 2752/4885HSD17B10 1163/4885NPSR1 1677/4885 |
| US-20090240072-A1 | Mixing Device for Liquids | SAMM50, CUL5, UBE3A | ALDH1A1 1631/4885HSD17B10 1080/4885NPSR1 3159/4885 |
| US-20090264612-A1 | ALKOXYSILANE-TERMINATED PREPOLYMERS | MYB, ACMSD, PLOD1 | ALDH1A1 1224/4885HSD17B10 3397/4885NPSR1 1982/4885 |
| US-20260028450-A1 | SILANE-TERMINATED POLYMERS | ILK, AKT1, PCNA | ALDH1A1 3186/4885HSD17B10 1427/4885NPSR1 1382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.